Thelma Tauya

Motivations for Starting and Stopping PrEP: Experiences of Adolescent Girls and Young Women in the HPTN 082 Trial

Lisa Mills, Makhosazane Nomhle Ndimande-Khoza, Jennifer Velloza, Millicent Atujuna et autres

Afrique du Sud, us, Zimbabwe (code pays fourni par la source)

Adolescent Girls and Young Women Overcoming Adherence Challenges with Vaginal and Oral PrEP Use: A Longitudinal Qualitative Study from a Crossover Trial in South Africa, Uganda, and Zimbabwe

Mary Kate Shapley‐Quinn, Siyanda Tenza, Destry Jensen, Thelma Tauya et autres

us, Afrique du Sud, Rwanda, Zimbabwe, Ouganda, Kenya (code pays fourni par la source)

We choose: Adolescent girls and young women’s choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe

Millicent Atujuna, Kristin Williams, Sarah T. Roberts, Alinda M. Young et autres

Afrique du Sud, us, Zimbabwe, Kenya (code pays fourni par la source)

Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex

Erica N. Browne, Kristine Torjesen, Brenda Gati Mirembe, Thesla Palanee‐Phillips et autres

us, Ouganda, Afrique du Sud, Zimbabwe, Malawi (code pays fourni par la source)

Women’s experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring

Ariana W. K. Katz, Iván C. Balán, Krishnaveni Reddy, Juliane Etima et autres

us, Afrique du Sud, Ouganda, Zimbabwe, Kenya, ca (code pays fourni par la source)

Impact of Women’s Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa

Margaret W. Gichane, Ariana W. K. Katz, Kenneth Ngure, Rachel Scheckter et autres

us, Kenya, Afrique du Sud, Zimbabwe, Ouganda (code pays fourni par la source)

Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

Ashley Mayo, Erica N. Browne, Elizabeth Montgomery, Kristine Torjesen et autres

us, Afrique du Sud, Malawi, Zimbabwe, Ouganda (code pays fourni par la source)

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi, Ashley Mayo et autres

us, Afrique du Sud, Zimbabwe, Ouganda, Malawi, Kenya (code pays fourni par la source)

Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial

Elizabeth Pleasants, Thelma Tauya, Krishnaveni Reddy, Brenda Gail Mirembe et autres

us, de, Zimbabwe, Afrique du Sud, Ouganda, Malawi (code pays fourni par la source)

New fallacies about HIV-AIDS in Zimbabwe

K. Nyamayaro Mufuka, Thelma Tauya